Australian Prescriber

📘February issue now available➡️bit.ly/4kmo8ec This issue explores psychotropic medicines in people with cognitive disability or impairment, ADHD management in adults, and more! #healthcare #freejournal #independentpeerreview

📢 The brand-new #TherapeuticGuidelines on Kidney and Urinary have landed. What do GPs need to know? 🎙️ Expert group member Lee Fong returns to the podcast to talk to host Justin Coleman about the new content, focusing on GP management. 🎧Listen now: bit.ly/4cUTXIO

How is MAFLD managed in primary care? 🎙️Laura Beaton talks to hepatology research fellow Richard O’Halloran about an update on risk factors, diagnosis, risk stratification and management. 🎧Start listening now: bit.ly/4vZaXoS

#CMV is the most common congenital infection in Australia, affecting around 1 in 200 births. This article provides an overview of congenital CMV, including when to test, how to interpret test results and the emerging role of valaciclovir. bit.ly/4my8zkA

☀️Vitamin B12 deficiency can lead to neurological and haematological problems if untreated. Find out when and whom to test for #vitamin #B12 deficiency, which tests to use and how to manage deficiency. 👉 bit.ly/4moddS6

💡 Accurately measuring blood pressure is imperative for the diagnosis and management of hypertension. This article summarises different methods and devices for measuring blood pressure, and factors that influence measurement accuracy. 🔗 Read now: bit.ly/4dDuHaT

🎙️How can #CMV infection risk be reduced in pregnancy? Dhineli Perera speaks with maternal–fetal medicine specialist Lisa Hui about strategies to reduce infection risk and the role of valaciclovir in reducing fetal transmission. 🎧Listen now: bit.ly/4cEUXQ7

Metabolic dysfunction-associated fatty liver disease (#MAFLD) is a common and growing cause of liver cirrhosis, hepatocellular carcinoma and reason for liver transplantation. This article outlines an approach to diagnosing and managing MAFLD. 👉 bit.ly/3O9mcd9

💻 The April issue is now available! Articles include updates on metabolic dysfunction-associated fatty liver disease (#MAFLD), accurate blood pressure measurement, vitamin #B12 deficiency, and more! 🔗 Explore the issue now: bit.ly/4bG3QcQ #healthcare

💡How can infection risk be reduced in immunosuppressed patients? Dhineli Perera speaks to infectious diseases physicians Aadith Ashok and Bradley Gardiner about risk assessment, screening, antimicrobial prophylaxis and safe living advice. 🎧Listen now: bit.ly/4bO1CXF

💡Is intra-articular hyaluronic acid (viscosupplementation) effective for osteoarthritis? David Liew talks with rheumatologist Jessica Pisaniello about the limited benefits, the risks and what guideline recommendations. 🎧Listen now: bit.ly/4ln31sw

📖 A new Australian guideline for diagnosing and managing acute coronary syndromes was launched in 2025. Get an overview of key pharmacological recommendations and their rationale. bit.ly/4tXRR1s @heartfoundation @thecsanz

📣NEW EP - 2025 Australian #ACS guideline highlights important updates in secondary prevention. Laura Beaton speaks with David Brieger, head of cardiology at Concord Hospital, about secondary prevention strategies recommended in the new guideline. Listen👂 bit.ly/4kO9cWe

Did you know patients taking #immunosuppressive drugs have a higher risk of #infection? A dedicated pre-immunosuppression assessment can help reduce this risk. Learn more: bit.ly/4aIqqzR @BradGardiner6 @aadith_ashok #healthcare

#Viscosupplementation with intra-articular hyaluronic acid injections is increasingly used to treat symptomatic osteoarthritis in the knee and other joints, but is it safe and effective? Tap to learn more👉 bit.ly/4rG2Bzf #hyaluronicacid #hylans

📈#ADHD is a common neurodevelopmental disorder that affects around 3 to 5% of adults. #Psychostimulants, such as lisdexamfetamine, dexamfetamine and methylphenidate, are the main medications used for ADHD. Learn about prescribing ADHD medicines: bit.ly/3O9rWmU

🧩 How is ADHD managed pharmacologically in adults? Justin Coleman speaks with psychiatrist Shuichi Suetani about prescribing considerations, adverse effects, monitoring and assessing treatment response in adult ADHD. 🎧 Listen now: bit.ly/4ah35X3

🎈#Psychotropic medicines are sometimes used in people with cognitive #disability or impairment. Learn about best-practice management of behaviours of concern, with a focus on psychotropic medicines 👉 bit.ly/4qYnPbW #cognitiveimpairment #agedcare

🧐There is often uncertainty about which medicines are considered ‘#psychotropic’ in aged and disability care settings. This editorial discusses the definitions of ‘psychotropic medicines’ and why they are subject to specific regulation. Read 👀 bit.ly/4kjFIiM #agedcare

💡 What role do injectable medicines play in weight management? Jo Cheah speaks with Terri-Lynne South about GLP-1 medicines, prescribing considerations, adverse effects and lifestyle support. 🎧 Listen now: bit.ly/3NH6g19